Tapewire

NYSE · USD

CI

Cigna Group

Export transactions ↓
Tapewire entity
550
SEC CIK
0001739940
Parsed reports
653

Last 12 months

Inside the activity.

1 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 2026013
Jun 202601
Jul 202600
Aug 202602
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 28, 2020 Filed Mar 2, 2020 20:47 UTC
MURABITO JOHN MEVP, HR & Services
Tax withholdingCommon Stock, $.01 Par Value 1,358 $179.41 $243,638.78
Disclosure

SEC source: 0001225208-20-003959 · doc4.xml · nonDerivative · entry 3

MURABITO JOHN M · CIK 0001126222 · EVP, HR & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,100

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 20:47 UTC
MURABITO JOHN MEVP, HR & Services
GrantCommon Stock, $.01 Par Value 4,384 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003959 · doc4.xml · nonDerivative · entry 2

MURABITO JOHN M · CIK 0001126222 · EVP, HR & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,458

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
Miller Steven BEVP, Chief Clinical Officer
Tax withholdingCommon Stock, $.01 Par Value 1,426 $182.94 $260,872.44
Disclosure

SEC source: 0001225208-20-003962 · doc4.xml · nonDerivative · entry 4

Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,104

F4 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
Miller Steven BEVP, Chief Clinical Officer
Tax withholdingCommon Stock, $.01 Par Value 858 $179.41 $153,933.78
Disclosure

SEC source: 0001225208-20-003962 · doc4.xml · nonDerivative · entry 3

Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,530

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
Miller Steven BEVP, Chief Clinical Officer
GrantCommon Stock, $.01 Par Value 2,178 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003962 · doc4.xml · nonDerivative · entry 2

Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,388

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:59 UTC
Evanko Brian CPresident Government Business
Tax withholdingCommon Stock, $.01 Par Value 962 $179.41 $172,592.42
Disclosure

SEC source: 0001225208-20-003963 · doc4.xml · nonDerivative · entry 3

Evanko Brian C · CIK 0001722909 · President Government Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,691

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:59 UTC
Evanko Brian CPresident Government Business
GrantCommon Stock, $.01 Par Value 3,066 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003963 · doc4.xml · nonDerivative · entry 2

Evanko Brian C · CIK 0001722909 · President Government Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,653

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
BOXER MARK LEVP, Chief Information Officer
Tax withholdingCommon Stock, $.01 Par Value 957 $179.41 $171,695.37
Disclosure

SEC source: 0001225208-20-003961 · doc4.xml · nonDerivative · entry 3

BOXER MARK L · CIK 0001238506 · EVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,191

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
BOXER MARK LEVP, Chief Information Officer
GrantCommon Stock, $.01 Par Value 3,051 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003961 · doc4.xml · nonDerivative · entry 2

BOXER MARK L · CIK 0001238506 · EVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,148

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
Cordani DavidDirector · President & CEO
Tax withholdingCommon Stock, $.01 Par Value 19,503 $179.41 $3,499,033.23
Disclosure

SEC source: 0001225208-20-003960 · doc4.xml · nonDerivative · entry 3

Cordani David · CIK 0001318751 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,174

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
Cordani DavidDirector · President & CEO
GrantCommon Stock, $.01 Par Value 42,085 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003960 · doc4.xml · nonDerivative · entry 2

Cordani David · CIK 0001318751 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,677

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
Palmer Eric PEVP, Chief Financial Officer
Tax withholdingCommon Stock, $.01 Par Value 2,653 $179.41 $475,974.73
Disclosure

SEC source: 0001225208-20-003958 · doc4.xml · nonDerivative · entry 3

Palmer Eric P · CIK 0001710190 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,555

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:47 UTC
Palmer Eric PEVP, Chief Financial Officer
GrantCommon Stock, $.01 Par Value 6,940 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003958 · doc4.xml · nonDerivative · entry 2

Palmer Eric P · CIK 0001710190 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,208

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Triplett Michael WPresident, US Markets
Tax withholdingCommon Stock, $.01 Par Value 1,033 $179.41 $185,330.53
Disclosure

SEC source: 0001225208-20-003957 · doc4.xml · nonDerivative · entry 3

Triplett Michael W · CIK 0001698840 · President, US Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,960

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Triplett Michael WPresident, US Markets
GrantCommon Stock, $.01 Par Value 3,431 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003957 · doc4.xml · nonDerivative · entry 2

Triplett Michael W · CIK 0001698840 · President, US Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,993

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
WENTWORTH TIMOTHY CPresident, Health Services
Tax withholdingCommon Stock, $.01 Par Value 9,330 $182.94 $1,706,830.20
Disclosure

SEC source: 0001225208-20-003956 · doc4.xml · nonDerivative · entry 4

WENTWORTH TIMOTHY C · CIK 0001252016 · President, Health Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,479

F4 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
WENTWORTH TIMOTHY CPresident, Health Services
Tax withholdingCommon Stock, $.01 Par Value 7,974 $179.41 $1,430,615.34
Disclosure

SEC source: 0001225208-20-003956 · doc4.xml · nonDerivative · entry 3

WENTWORTH TIMOTHY C · CIK 0001252016 · President, Health Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,809

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
WENTWORTH TIMOTHY CPresident, Health Services
GrantCommon Stock, $.01 Par Value 17,817 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003956 · doc4.xml · nonDerivative · entry 2

WENTWORTH TIMOTHY C · CIK 0001252016 · President, Health Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,783

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Sadler Jason DPres., International Markets
GrantCommon Stock, $.01 Par Value 4,384 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003955 · doc4.xml · nonDerivative · entry 1

Sadler Jason D · CIK 0001554974 · Pres., International Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,482

F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Manders Matthew GPresident, Strategy & Solution
Tax withholdingCommon Stock, $.01 Par Value 2,336 $179.41 $419,101.76
Disclosure

SEC source: 0001225208-20-003954 · doc4.xml · nonDerivative · entry 3

Manders Matthew G · CIK 0001480601 · President, Strategy & Solution

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,987

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Manders Matthew GPresident, Strategy & Solution
GrantCommon Stock, $.01 Par Value 6,305 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003954 · doc4.xml · nonDerivative · entry 2

Manders Matthew G · CIK 0001480601 · President, Strategy & Solution

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,323

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Jones Nicole SEVP, General Counsel
Tax withholdingCommon Stock, $.01 Par Value 2,253 $179.41 $404,210.73
Disclosure

SEC source: 0001225208-20-003953 · doc4.xml · nonDerivative · entry 3

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,864

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Jones Nicole SEVP, General Counsel
GrantCommon Stock, $.01 Par Value 6,246 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003953 · doc4.xml · nonDerivative · entry 2

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,117

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
Tax withholdingCommon Stock, $.01 Par Value 554 $179.41 $99,393.14
Disclosure

SEC source: 0001225208-20-003952 · doc4.xml · nonDerivative · entry 3

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,240

F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 01:46 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
GrantCommon Stock, $.01 Par Value 1,781 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003952 · doc4.xml · nonDerivative · entry 2

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,794

F2 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 17:07 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004186 · doc4.xml · nonDerivative · entry 1

ROPER WILLIAM L · CIK 0001087960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,623

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:07 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004188 · doc4.xml · nonDerivative · entry 1

ZARCONE DONNA F · CIK 0001243083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,059

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:07 UTC GrantPhantom Stock Units · Derivative 181 $182.94 $33,112.14
Disclosure

SEC source: 0001225208-20-004187 · doc4.xml · derivative · entry 2

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,976

Underlying: Common Stock, $.01 Par Value · 181 shares

Expires not disclosed

F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:07 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004187 · doc4.xml · nonDerivative · entry 1

WISEMAN ERIC C · CIK 0001237851 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,646

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:07 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004185 · doc4.xml · nonDerivative · entry 1

PARTRIDGE JOHN · CIK 0001319897 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,676

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:06 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004184 · doc4.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,597

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:06 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004183 · doc4.xml · nonDerivative · entry 1

MAZZARELLA KATHLEEN M · CIK 0001273233 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,597

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:06 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004182 · doc4.xml · nonDerivative · entry 1

MARTINEZ ROMAN IV · CIK 0001276303 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,105

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:06 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004180 · doc4.xml · nonDerivative · entry 1

Granger Elder · CIK 0001625579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,119

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:06 UTC
HARRIS ISAIAH JRDirector · Chairman of the Board
GrantCommon Stock, $.01 Par Value 314 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004181 · doc4.xml · nonDerivative · entry 1

HARRIS ISAIAH JR · CIK 0001202287 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,061

F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 32 and 93 of Cigna's proxy statement filed with the SEC on March 15, 2019.

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:06 UTC GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004178 · doc4.xml · nonDerivative · entry 1

DeLaney William J III · CIK 0001384151 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,272

Read SEC document
February 28, 2020 Filed Mar 3, 2020 22:06 UTC
FOSS ERIC JDirector
GrantCommon Stock, $.01 Par Value 259 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-004179 · doc4.xml · nonDerivative · entry 1

FOSS ERIC J · CIK 0001197007 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,942

Read SEC document
February 27, 2020 Filed Mar 2, 2020 20:47 UTC
MURABITO JOHN MEVP, HR & Services
Tax withholdingCommon Stock, $.01 Par Value 239 $185.76 $44,396.64
Disclosure

SEC source: 0001225208-20-003959 · doc4.xml · nonDerivative · entry 1

MURABITO JOHN M · CIK 0001126222 · EVP, HR & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,074

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:47 UTC
Miller Steven BEVP, Chief Clinical Officer
Tax withholdingCommon Stock, $.01 Par Value 149 $185.76 $27,678.24
Disclosure

SEC source: 0001225208-20-003962 · doc4.xml · nonDerivative · entry 1

Miller Steven B · CIK 0001599611 · EVP, Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,210

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:59 UTC
Evanko Brian CPresident Government Business
Tax withholdingCommon Stock, $.01 Par Value 257 $185.76 $47,740.32
Disclosure

SEC source: 0001225208-20-003963 · doc4.xml · nonDerivative · entry 1

Evanko Brian C · CIK 0001722909 · President Government Business

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,587

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:47 UTC
BOXER MARK LEVP, Chief Information Officer
Tax withholdingCommon Stock, $.01 Par Value 185 $185.76 $34,365.60
Disclosure

SEC source: 0001225208-20-003961 · doc4.xml · nonDerivative · entry 1

BOXER MARK L · CIK 0001238506 · EVP, Chief Information Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,097

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:47 UTC
Cordani DavidDirector · President & CEO
Tax withholdingCommon Stock, $.01 Par Value 2,035 $185.76 $378,021.60
Disclosure

SEC source: 0001225208-20-003960 · doc4.xml · nonDerivative · entry 1

Cordani David · CIK 0001318751 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,592

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:47 UTC
Palmer Eric PEVP, Chief Financial Officer
Tax withholdingCommon Stock, $.01 Par Value 548 $185.76 $101,796.48
Disclosure

SEC source: 0001225208-20-003958 · doc4.xml · nonDerivative · entry 1

Palmer Eric P · CIK 0001710190 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,268

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:46 UTC
Triplett Michael WPresident, US Markets
Tax withholdingCommon Stock, $.01 Par Value 266 $185.76 $49,412.16
Disclosure

SEC source: 0001225208-20-003957 · doc4.xml · nonDerivative · entry 1

Triplett Michael W · CIK 0001698840 · President, US Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,562

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:46 UTC
WENTWORTH TIMOTHY CPresident, Health Services
Tax withholdingCommon Stock, $.01 Par Value 1,220 $185.76 $226,627.20
Disclosure

SEC source: 0001225208-20-003956 · doc4.xml · nonDerivative · entry 1

WENTWORTH TIMOTHY C · CIK 0001252016 · President, Health Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,966

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:46 UTC
Manders Matthew GPresident, Strategy & Solution
Tax withholdingCommon Stock, $.01 Par Value 548 $185.76 $101,796.48
Disclosure

SEC source: 0001225208-20-003954 · doc4.xml · nonDerivative · entry 1

Manders Matthew G · CIK 0001480601 · President, Strategy & Solution

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,018

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:46 UTC
Jones Nicole SEVP, General Counsel
Tax withholdingCommon Stock, $.01 Par Value 395 $185.76 $73,375.20
Disclosure

SEC source: 0001225208-20-003953 · doc4.xml · nonDerivative · entry 1

Jones Nicole S · CIK 0001492663 · EVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,871

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 27, 2020 Filed Mar 3, 2020 01:46 UTC
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
Tax withholdingCommon Stock, $.01 Par Value 83 $185.76 $15,418.08
Disclosure

SEC source: 0001225208-20-003952 · doc4.xml · nonDerivative · entry 1

Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,013

F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 21:27 UTC
MURABITO JOHN MEVP, HR & Services
GrantEmployee Stock Option (Right to Buy) · Derivative 8,578 $0.00 Strike: $192.02 $0.00
Disclosure

SEC source: 0001225208-20-003812 · doc4.xml · derivative · entry 3

MURABITO JOHN M · CIK 0001126222 · EVP, HR & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,578

Underlying: Common Stock, $.01 Par Value · 8,578 shares

Expires 2030-02-26

F3 · derivative.exercise_date: This option vests in three equal annual installments beginning February 26, 2021.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 21:27 UTC
MURABITO JOHN MEVP, HR & Services
GrantCommon Stock, $.01 Par Value 2,344 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-003812 · doc4.xml · nonDerivative · entry 1

MURABITO JOHN M · CIK 0001126222 · EVP, HR & Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,313

F1 · shares: These restricted shares vests in three equal annual installments beginning February 26, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.